Zoetis Inc.’s stock price dips to $183.38, marking a 2.65% decrease: Time to Buy?

Zoetis Inc. (ZTS)

183.38 USD -5.00 (-2.65%) Volume: 2.14M

Experiencing a trading session dip of -2.65%, Zoetis Inc.’s stock price stands at 183.38 USD, with a trading volume of 2.14M. Despite a YTD percentage change of -7.09%, the company maintains a steady presence in the market.

Latest developments on Zoetis Inc.

Zoetis Inc. (NYSE:ZTS) has seen a 5.1% jump in stock price this week, despite earnings growth lagging behind five-year shareholder returns. Analysts are optimistic about the company’s future, with projections that sales of their drug Librela could exceed management’s $1 billion target by 200-300%. This positive outlook has led to various investment firms, such as LVW Advisors LLC, Blue Zone Wealth Advisors LLC, Dynamic Advisor Solutions LLC, and RFG Advisory LLC, increasing their stock positions in Zoetis. BTIG Research has also raised Zoetis’ price target to $225.00, indicating further potential growth for the company. Bank Pictet & Cie Asia Ltd. recently acquired 10,900 shares of Zoetis, reflecting continued investor confidence in the pharmaceutical company’s performance.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Zoetis has a positive long-term outlook overall. The company scores highest in momentum, indicating strong market performance and investor interest. This suggests that Zoetis is likely to continue to attract attention and potentially see further growth in the future. While the company’s value and resilience scores are lower, its growth and dividend scores are moderate, indicating a stable and growing business model.

Zoetis Inc. is a leading player in the animal health industry, with a focus on developing medicines and vaccines for both livestock and companion animals. With a strong presence in multiple regions around the world, including North America, Europe, and Asia, Zoetis is well-positioned for continued success and growth. Investors may find Zoetis to be an attractive option for long-term investment, given its solid performance in key areas such as momentum and growth.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma